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School of Medicine, Baltimore, MarylandABSTRACT Stretching single ventricular cardiac myocytes has been shown experimentally to activate transmembrane nico-
tinamide adenine dinucleotide phosphate oxidase type 2 to produce reactive oxygen species (ROS) and increase the Ca2þ spark
rate in a process called X-ROS signaling. The increase in Ca2þ spark rate is thought to be due to an increase in ryanodine re-
ceptor type 2 (RyR2) open probability by direct oxidation of the RyR2 protein complex. In this article, a computational model is
used to examine the regulation of ROS and calcium homeostasis by local, subcellular X-ROS signaling and its role in cardiac
excitation-contraction coupling. To this end, a four-state RyR2 model was developed that includes an X-ROS-dependent
RyR2 mode switch. When activated, [Ca2þ]i-sensitive RyR2 open probability increases, and the Ca
2þ spark rate changes in
a manner consistent with experimental observations. This, to our knowledge, new model is used to study the transient effects
of diastolic stretching and subsequent ROS production on RyR2 open probability, Ca2þ sparks, and the myoplasmic calcium
concentration ([Ca2þ]i) during excitation-contraction coupling. The model yields several predictions: 1) [ROS] is produced locally
near the RyR2 complex during X-ROS signaling and increases by an order of magnitude more than the global ROS signal during
myocyte stretching; 2) X-ROS activation just before the action potential, corresponding to ventricular filling during diastole, in-
creases the magnitude of the Ca2þ transient; 3) during prolonged stretching, the X-ROS-induced increase in Ca2þ spark rate is
transient, so that long-sustained stretching does not significantly increase sarcoplasmic reticulum Ca2þ leak; and 4) when the
chemical reducing capacity of the cell is decreased, activation of X-ROS signaling increases sarcoplasmic reticulum Ca2þ leak
and contributes to global oxidative stress, thereby increases the possibility of arrhythmia. The model provides quantitative infor-
mation not currently obtainable through experimental means and thus provides a framework for future X-ROS signaling
experiments.INTRODUCTIONReactive oxygen species (ROS) are oxygen-derived mole-
cules that play a significant role in physiological processes.
ROS are involved in cellular signaling by mediating
the posttranslational modifications of various proteins, com-
monly through oxidation of sulfhydryl (SH) groups in
cysteine residues (1,2). Lipid bilayer studies incorporating
sarcoplasmic reticulum (SR) vesicles have focused on sulf-
hydryl oxidation of the ryanodine receptor 2 (RyR2) chan-
nel complex (3,4). This ROS-induced sensitization of
RyR2 increases [Ca2þ]i sensitivity, increasing RyR2 open
probability (Po) and hence the frequency of Ca
2þ sparks (5).
Modulation of RyR2 activity by redox active compounds
depends on the type and concentration of these compounds.
The overall concentration of oxidizing and reducing agents
in a cell determines the intracellular redox potential of the
cell (4,6). At low concentrations, the redox active com-
pounds are capable of reversibly oxidizing the RyR2s (or
any other targets) to tune their function. However, at larger
concentrations, these compounds can activate RyR2s irre-Submitted April 9, 2015, and accepted for publication September 23, 2015.
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hyperactivity of RyR2 channels. This increases Ca2þ leak
and decreases SR Ca2þ content, resulting in diminished
SR Ca2þ release and weakened muscle contraction during
systole. Under some conditions, these same events may
increase the risk of arrhythmia. Oxidative stress (OS) can
thus lead to pathological conditions such as systolic
dysfunction, arrhythmia, and heart failure (HF) (8). In the
event of pathological conditions such as HF, a decrease
in the ratio of reduced to oxidized glutathione elevates
cytosolic ROS levels, thus increasing the redox modifica-
tion of RyR2 channels, resulting in enhanced SR Ca2þ
leak (9).
In the working heart, diastolic stretching of ventricular
cardiac myocytes occurs with every heartbeat as the ventri-
cles fill with blood. This cellular extension activates mem-
brane-bound nicotinamide adenine dinucleotide phosphate
(NADPH) oxidase type 2 (Nox2)-dependent ROS produc-
tion in a process that depends on the microtubule cytoskel-
eton. These elements lead to a burst of elevated ROS in
the dyadic subspace in a process termed X-ROS signaling.
The dyadic subspace is the microdomain created at the Z-
line bounded by the junctional SR and transverse tubulehttp://dx.doi.org/10.1016/j.bpj.2015.09.031
2038 Limbu et al.(T-tubule) membranes. The locally elevated ROS increases
the sensitivity of RyR2s to [Ca2þ]i, thus triggering a burst
of diastolic Ca2þ sparks, rapid Ca2þ release events from
the SR (10,11). N-acetylcysteine (NAC), an antioxidant
that scavenges ROS and reactive nitrogen species (RNS),
as well as diphenyleneiodonium (DPI) and gp91ds-tat,
both Nox2 inhibitors, all block the stretch-induced burst
of Ca2þ sparks, identifying Nox2 as the source of ROS
(11,12). Stretching the cardiomyocytes of a mouse model
of Duchenne muscular dystrophy (the mdx mouse) reveals
that such stretch-induced ROS production can result in ar-
rhythmogenic Ca2þ waves. Of note, a similar X-ROS mech-
anism has been identified in skeletal muscle, but with
important and distinctive differences (13).
To examine our understanding of X-ROS signaling
and explore how it might play a role in cellular physiology
and pathophysiology, a computational model of excitation-
contraction (EC) coupling and Ca2þ signaling in the heart
was created that included stretch-induced X-ROS sig-
naling. In this model, RyR2 SR Ca2þ release channels
could be reversibly activated by local ROS and depended
on the cytosolic redox state. This model simulates the
experimentally observed stretch-induced ROS production
and the sudden burst of Ca2þ sparks upon stretching.
The kinetics of the process is consistent with the hypoth-
esized local reversible ROS signaling. Furthermore, the
model demonstrates how X-ROS signaling may lead to
altered local Ca2þ signaling and OS during changes in
cellular redox status. This model accounts for Ca2þ
signaling changes that are attributed to X-ROS signaling
in the heart.MATERIALS AND METHODS
The model
A new Ca2þ-spark-based model of EC coupling in cardiac ventricular
myocytes has been developed to include X-ROS signaling. To this end,
the rat ventricular myocyte model for EC coupling used in Wagner et al.
(14) is extended to include a description of X-ROS signaling. The model
(Fig. 1) includes 20,000 calcium release units (CRUs), each containing
49 stochastically gating RyR2s and seven stochastically gating L-type
Ca2þ channels (LCCs) interacting via the dyadic-subspace [Ca2þ]
([Ca2þ]ds). The dyadic subspaces equilibrate by diffusion with a myoplas-
mic [Ca2þ] ([Ca2þ]i) compartment. The opening rate of the Ca
2þ-gated
RyR2 homotetramer is sensitive to both the [Ca2þ]ds and the junctional
SR (JSR) luminal [Ca2þ] ([Ca2þ]JSR). During diastole, the LCCs are nor-
mally closed and Ca2þ release from the JSR RyR2s is initialized by the
probabilistic openings of RyR2s themselves. During systole, Ca2þ release
via opening of the RyR2 channels is initiated by the rise in the subspace
Ca2þ entering due to the opening of one or more voltage-gated LCCs.
Once Ca2þ release in a CRU is initiated, then the nature of a Ca2þ spark
is similar whether the release was initiated in diastole or systole. Inclusion
of X-ROS signaling requires the development of an RyR2 model that de-
scribes the action of ROS on RyR2 open probability. Therefore, we devel-
oped, to our knowledge, a novel four-state model consisting of the closed
state (C1) and the open state (O1) in mode 1, and a new closed state (C2)
and open state (O2) in mode 2. The conducting levels at states O1 and O2
are the same. At basal ROS levels, the RyR2s mostly function in mode 1Biophysical Journal 109(10) 2037–2050and are similar to the two-state Markov chain developed by Williams
et al. (15) (Fig. 2, Mode 1). On the other hand, in the presence of stretch-
induced ROS production, the RyR2s have a higher possibility of being
oxidized by ROS and switching to mode 2 (Fig. 2). In mode 2, the transition
probability from closed state C2 to open state O2 is higher than the mode 1
transition probability from closed state C1 to open state O1. In the presence
of ROS, the overall lifetime of channels in the open state increases and that
in the closed state decreases, as observed by Boraso et al. (5). Hence, for
mode 2, the association rate constant (k1þ) is increased and the dissociation
rate constant (k1) is decreased compared to mode 1. The function 4 (¼
4m[Ca
2þ]JSR þ 4b), describing the effect of luminal Ca2þ on opening,
and the dependence term h, describing the positive feedback of [Ca2þ]ds,
remain unchanged for the two modes. The probability of transition of an
RyR2 from mode 1 to mode 2 (from C1 to C2) depends upon the rate con-
stant for oxidation by [ROS]ds (k2
þ) (16) and the dependence on [ROS]ds, b.
The transition probability from mode 2 to mode 1 is dependent on the
reduction rate constant (k2). This rate falls in the experimental range for
the oxidation of thiols (16) and is further constrained to give appropriate
activation and deactivation dynamics to match experimental results by
Prosser et al. (11).Modeling methods
The ordinary differential equations for Ca2þ dynamics calculations are the
same N ¼ 20,000 equations representing the Markov chain Monte Carlo
model described by Williams et al. (15). During diastolic stretching, it is
assumed that ROS is produced at the membranes of each release site
equally. The ordinary differential equations for calculating the ROS con-
centration in the kth dyadic subspace and the myoplasm are given by
Eqs. 1 and 2.
ROS in subspace is described by the differential equation
d½ROSkds
dt
¼ 1
lds

JkROSProduction  JkROSEfflux  JkROSReductionds

;
(1)
and ROS in myoplasm is described by the differential equationd½ROSi
dt
¼ JTROSEfflux  JROSReductioni ; (2)
where lds ¼ Vds=Vmyo is the fraction of myoplasmic volume for the dyadic
subspace, VT is the total dyadic subspace volume, and V ¼ VT =N. Theds ds ds
index k is any one of the subspace (1 % k % N). The flux of ROS from
the kth subspace to the bulk myoplasm is given by
JkROSEfflux ¼
vTROSEfflux
N

½ROSkds  ½ROSi

: (3)
The total flux of ROS from N dyadic subspace to the myoplasm is given by
JTROSEfflux ¼
XN
k¼ 1
JkROSEfflux
¼
XN
k¼ 1
vTROSEfflux
N

½ROSkds  ½ROSi

; (4)
where vTRosEfflux is the rate of total ROS efflux out of the subspace.
Because it is assumed that each subspace releases the same amount of
ROS, the above equation becomes
JTROSEfflux ¼ vTROSEfflux

½ROSkds  ½ROSi

: (5)
FIGURE 1 Schematic of the calcium handling
model. ROS are produced by Nox2 at the Ca2þ
release site as a result of stretching. Only one of
the 20,000 Ca2þ release units is shown. Purple cir-
cles indicate calcium ions (Ca2þ). NCX, Naþ-Ca2þ
exchanger; PMCA, plasmalemmal Ca2þ-ATPase;
INa, sodium current; Ito, transient outward potas-
sium current; IK1, potassium current; LCC, L-type
Ca2þ current; RYR2, ryanodine receptor channel;
ROS, reactive oxygen species; Nox2, NADPH oxi-
dase type 2; CSQ, calsequestrin; JSR, junctional
SR; NSR, network SR; CaM, calmodulin; GSH,
reduced glutathione. To see this figure in color, go
online.
Modeling X-ROS Signaling 2039The amount of ROS removed from each subspace is given by
JkROSReductionds ¼ vROSReductionðldsÞðGSHÞ

½ROSkds

: (6)
The amount of ROS removed from the bulk myoplasm is given by
JROSReductioni ¼ vROSReduction
ðGSHÞ½ROSi  ½ROSibase;
(7)FIGURE 2 The four-state mode-switching model of a single RyR2. The
RyR2 channels assume mode 1 in the absence of ROS. Elevation of ROS
causes a fraction of the channels to switch from mode 1 to mode 2, which
displays a higher open probability due to an increased opening rate and
decreased closing rate. C1, closed-state mode 1; O1, open-state mode 1;
C2, closed-state mode 2; O2, open-state mode 2; 4, SR luminal dependence
function; k1þ, association rate constant; k1, dissociation rate constant;
k2þ, oxidizing rate constant; k2, reduction rate constant; h, cooperativity
of activating Ca2þ binding to RyR2.where vROSReduction is the rate of ROS removal and ½ROSibase is the base
(steady-state) ROS concentration in the myoplasm. The relative concentra-
tion of the reduced form of glutathione is (GSH) ¼ 1 under normal physi-
ological conditions, i.e., without OS.
When stretched, the actual amount of ROS produced ðJkROSProductionÞ by
Nox2 in each subspace (see Fig. 4 C) is given by a set of four time-depen-
dent equations:
1) JkROSProduction ¼ ROSpreStr þ ð:0002ROSpreStrÞ:12 t for t < tStr
2) JkROSProduction ¼ .000036(t2)  .000122(t) þ .000214 tStr% t < 1.5 s
3) JkROSProduction ¼ .000001(t2) .0000152(t)þ .0001326716 1.5 s% t< 4 s
4) JkROSProduction ¼ .0001259488(exp–.09t) t R 4 s,
where ROSpreStr is the rate of stretch-induced ROS production just before
the stretching is done (¼ JkROSProduction at the time of stretching) and is equal
to 0 s1 in the resting condition, and tStr is the time taken to reach peak
stretching. The coefficients and order of the equations were selected
such that the outcome would resemble the trend of the ROS production
rate obtained experimentally by Prosser et al. (11). The case when myo-
cyte length is returned to normal is referred to here as release of stretch.
If time_after_release % timeROSEnd (the time taken for stretch-induced
ROS production to cease after the release of stretch), then
5) JkROSProduction ¼ ROSprerelease

1 time_after_releasetimeROSEnd

;
where ROSprerelease is the rate of ROS production just before the release of
stretch is done (¼ JkROSProduction at the time of release of stretch).
The rate of ROS production is observed experimentally using 20,70-di-
chlorofluorescein (DCF) fluorescence, which is activated by ROS. The
model describes the activation of DCF in the subspace and myoplasm by
the fluxes into the activated state as
JROSDCFedds ¼ vROSDCFð½DCFÞ

½ROSkds

(9)
JROSDCFedi ¼ vROSDCFð½DCFÞ
½ROSi; (10)Biophysical Journal 109(10) 2037–2050
2040 Limbu et al.where vROSDCF is the rate of DCF activation by ROS.
The total concentration of ROS-activated DCF is thus given by
d½ROSDCFedTotal
dt
¼
ðVdsÞðJROSDCFeddsÞþVmyoðJROSDCFediÞ
VdsþVmyo :
(11)
Constraining the model: Ca2D dynamics
The newly developed EC coupling model for rat ventricular cardiac myo-
cytes is able to produce Ca2þ spark frequency results similar to the exper-
imental results reported by Prosser et al. (11). When a cell is stretched for a
continuous 10 s period from a resting slack length of ~1.8 mm sarcomere
spacing to a longer length, the number of Ca2þ sparks increases rapidly
by about twofold and then drops gradually during the 10 s of sustained
stretching (Fig. 3 A). The Ca2þ spark frequency drops by ~25% by the
end of the 10 s period of stretching and then rapidly drops to its prestretched
level within a second of its return to its control length.
With the increase in the Ca2þ spark rate during stretching, the model ex-
hibits a small transient rise in [Ca2þ]i and a correspondingly small decrease
in the network SR (NSR) [Ca2þ] ([Ca2þ]NSR), as seen in Fig. 3, B and C,
respectively. These findings, although clearly demanded by mass action,
are seen quantitatively here. The spark rate drops gradually during the
10 s of sustained stretching, mainly due to the gradual drop in ROS concen-
tration. The NSR Ca2þ concentration does play a small role, as demon-
strated in Fig. 3, A and C, by comparing the values both pre- and
poststretching. There is a small decline in spark rate poststretch (Fig. 3
A) due to the slightly lower NSR Ca2þ concentration (Fig. 3 C).Constraining the model: ROS dynamics
The basal steady-state [ROS] used in the model is assumed to be 10 nM,
which is similar to the physiological level of H2O2 estimated from experi-
ments (%20 nM) (16,17). In the simulations, only 50% of the myocyte was
considered during stretching and release of stretch protocols to be consis-
tent with experiments that only stretch a portion of the myocyte. The vol-
umes and model components have been scaled to reflect this. The bulk
myoplasmic [ROS] ([ROS]i) is estimated to peak at 0.6 mM during the sus-
tained stretching (Fig. 4 A). This estimation is consistent with Barbieri et al.
(18), where it is stated that ROS generation increases from 50- to 100-fold
during skeletal muscle contraction. The dyadic subspace transients
([ROS]ds) are predicted to be 10-fold higher than the myoplasmic values
([ROS]i) with faster rising and falling kinetics (Fig. 4 B). The shape of
the time-dependent [ROS]ds closely follows the ROS production flux due
to the small size of the subspace (Fig. 4 C).
Experimental estimation ofmyoplasmic ROS concentrationmeasured us-
ing DCF fluorescence is simulated using Eqs. 10 and 11 and shown in Fig. 4,
D andE, respectively, as the concentration ofROS-activatedDCF. The calcu-Biophysical Journal 109(10) 2037–2050lated value of the total ROS-activated DCF is similar in appearance to the
actual experimentally measured DCF fluorescence (11). This can be thought
of as simulated fluorescence. The rate of rise of ROS-activated DCF is adap-
tive rather than constant, as seen by the slightly better r2 value. This is sup-
ported further by the experiments with sustained stretch, which show that the
ROS production returns to normal levels if the stretch is sufficiently pro-
longed (12). For this reason, the model assumes that the ROS production
rate decreases with prolonged stretch (Fig. 4 F, blue). Fig. 4 F (red) shows
the consequence of a constant rate of ROS production. The fit to the data
for the adaptive production is slightly better than that of a constant rate of
ROS production. The assumption that ROS production occurs primarily in
release sites allows the generation of a significant increase in local ROS con-
centration that can sensitize the RyR2s, resulting in increased open probabil-
ity (see Fig. 6, below). This assumption allows ROS to rise locally near the
RyR2s while keeping cellular ROS concentrations below the presumably
toxicologically significant levels of >10 mM (19).Selection of parameters
The values of the parameters are specified in Table 1 along with reference to
their sources. Model parameters were selected within the following con-
straints: 1) the model output should match published experimental results;
2) parameters should fall within the range of experimentally determined
values; or 3) parameters should be derived from experimental observation.
The parameter adjustments were made by hand to obtain simulation results
in agreement with experimental data. The parameters for the opening rate
(kþ), closing rates (k), subspace volume ðVTdsÞ, and myocyte volume
ðVmyoÞ come from our previously published spark model, which was con-
strained by experimental observations (14,15). This constrains the parame-
ters for mode 1. Parameters for ROS regulation of the RyR2, i.e., mode 2,
were constrained from bilayer experiments that indicated that the channel
open dwell time increased twofold in the presence of H2O2, whereas the
closed dwell time decreased (5). This indicates that the closing rate in the
ROS oxidized state (k1) should be half that in the nonoxidized state
(k), whereas the opening rate (k1þ) should be increased over kþ.
The rate of transition from mode 1 to the ROS-oxidized mode 2 is not
well constrained by experimental measurements of thiol oxidation, which
have been reported to be in the range 10–106 M1 s1 (16). Therefore,
this transition rate (k2þ) is selected in this range and constrained further,
along with k2 and b, so that the response to stretching and recovery
from stretch response of the spark rate matches the experimental observa-
tions (11).
The parameters governing ROS dynamics are vTROSEfflux, vROSReduction,
timeROSEnd, and vROSDCF. These parameters were adjusted such that the
DCF activation rate in Fig. 4 D would closely match the derivative of the
experimental DCF fit in Prosser et al. (11), as shown in Fig. 4 E.
When constraining model parameters to match X-ROS experiments
simulated in Fig. 3 A, certain features were emphasized, such as the increase
in spark rate with the onset of stretching, the decline of the spark rate during
stretch, and the recovery of the spark rate after the relaxation of stretch. InFIGURE 3 Simulation results using the four-
state ventricular cardiac myocyte model (n ¼ 50
simulations) (A) Ca2þ spark histograms for 1 s
bins. Black solid circles show the experimental
data from Prosser et al. (11). (B) Myoplasmic
Ca2þ concentration ([Ca2þ]i). (C) Network SR
Ca2þ concentration ([Ca2þ]NSR). The myocyte is
stretched continuously from 10 to 20 s, displaying
a transient increase in the Ca2þ spark rate. To see
this figure in color, go online.
FIGURE 4 ROS dynamics during the stretching
protocol used in Fig. 3. (A) Concentration of ROS
in the myoplasm ([ROS]i). (B) Concentration of
ROS in the dyadic subspace ([ROS]ds) compared
to [ROS]i. (C) ROS production flux. (D) Rate of
ROS activation of DCF. (E) Total concentration
of activated DCF. The myocyte is stretched contin-
uously from 10 to 20 s. (F) The rate of ROS produc-
tion is adaptive (blue) rather than constant (red).
Black dashed lines in (E) and (F) show experi-
mental data from Prosser et al. (11). To see this
figure in color, go online.
Modeling X-ROS Signaling 2041Fig. 3 A, the data are separated into bins. The last bin before stretching is bin
10 and the first bin during the period of stretching is bin 11. Thus, the
amount of spark rate increase by stretching can be quantified as the ratio
of the value of bin 11 to that of bin 10, which serves as the first output quan-
tity calculated in the control coefficients. The ratio of bin 11 to bin 20,
which demonstrates the decline of spark rate during stretching, is the sec-
ond output quantity. The third output quantity is the ratio of bin 20 to bin
21, which shows the ratio of the last bin during stretching compared to
the first bin after stretching ends. This demonstrates the recovery of spark
rate from stretching. Fig. 5 demonstrates the sensitivity of the model by
showing the changes in these three model-output responses when the pa-
rameters b (dark blue), k1þ (light blue), k1 (fuchsia), k2þ (tan), and
k2 (brown) were each increased by 10% individually. The ratio of the
change in output response to the change in the parameter (control
coefficient ¼ DJ/Dp ¼ [{change in output}/{change in parameter}]) yields
the control coefficients, which are shown graphically. The numerical values
of the control coefficients are also shown in Table 2. The calculations of the
control coefficients show that the increase in spark rate due to stretching is
most sensitive to changes in b, but also very sensitive to k2, the transition
rate from mode 2 to mode 1 (Fig. 5, 11/10). The decline in spark rate during
stretching is most sensitive to b (Fig. 5, 11/20). The recovery from stretch-
ing is most sensitive to k2, the transition rate from mode 2 to mode 1
(Fig. 5, 20/21).RESULTS
The model of X-ROS signaling described above was
developed and shown to simulate experimentally observedTABLE 1 Parameters
Parameter Definition
k1þ association rate constant for RyR2 and Ca
k1 dissociation rate constant for RyR2 and Ca
k2þ oxidizing rate constant of RyR2 by
k2 reducing rate constant of RyR2
b dependence of RyR2 oxidation by
VTds total subspace volume
Vmyo myoplasmic volume
vTROSEfflux total rate of ROS efflux out of subs
vROSReduction rate of ROS removal
timeROSEnd time taken for stretch-induced ROS production to ceas
vROSDCF rate of DCF activation by ROSX-ROS signaling in the context of normal cellular and sub-
cellular Ca2þ signaling. In addition, this, to our knowledge,
new X-ROS model was designed to provide insight by
carrying out model-dependent experiments that could not
yet be done with single cells. Thus, simulations were per-
formed to suggest the physiological significance of X-
ROS signaling beyond that which is directly measurable
experimentally and to gain insight into how X-ROS
signaling may be altered in disease states and may con-
tribute to pathology.Mechanisms of X-ROS signaling
The simulation results shown in Figs. 3 and 4 assume that
ROS is produced locally in the membranes of subspace.
To test this assumption, the next set of simulations explores
the consequences of global ROS production during stretch,
i.e., at sarcolemmal and T-tubular membranes everywhere in
the cell. In the case of localized ROS release, when a cardi-
omyocyte is stretched, the concentration of subspace ROS
([ROS]ds) (Fig. 3 A) sharply increases due to rapid ROS pro-
duction during the process of stretching (first few millisec-
onds), but the decrease is also sharp initially due to the
decrease in the ROS production rate (after the stretchingValue Reference
2þ in mode2 24 mMh s1 (5)
2þ in mode2 250 s1 (5)
ROS 1 mMb s1 (16)
14 s1 (11)
ROS 0.4 (11)
0.027 pL (14,15)
18 pL (15)
pace 0.3125 s1 (11)
2 s1 (11)
e after release of stretch 0.6 s (11)
0.85 s1 (11)
Biophysical Journal 109(10) 2037–2050
FIGURE 6 Simulations demonstrating the consequences of global ROS
release. (A) Concentration of ROS in the myoplasm ([ROS]i). (B) Concen-
tration of ROS in the subspace ([ROS]ds). (C) The resulting spark frequency
for n ¼ 20 simulations. To see this figure in color, go online.
FIGURE 5 Control coefficients for uncertainty analysis of parameters b,
k1þ, k1, k2þ, and k2 (n ¼ 20 simulations). The parameters were varied
by 10%. Control coefficient ¼ d(output)/d(parameter) ¼ (output ratioi 
output ratioc)/(increased parameteri – control parameterc); output ratioi ¼
spark-count ratio of xth to yth bins for the increased parameter; output ratioc
¼ spark-count ratio of xth to yth bins for the control parameter, where x/y¼
11/10 (activation by stretch), 11/20 (decline during stretch), and 20/21 (re-
covery after end of stretch). To see this figure in color, go online.
2042 Limbu et al.is done and the myocyte is held at a constant length), as well
as to the ROS efflux from the subspace toward the bulk
myoplasm contributing to the myoplasmic ROS ([ROS]i)
(Fig. 3 B). This sharp increase and decline of [ROS]ds makes
the sudden twofold increase of spark rate within 0–1 s of the
stretch possible while making sure that, similar to the exper-
imental results, the spark frequency does not increase even
more during the 1–2 or 2–3 s after stretching (Fig. 3 A, solid
circles). In the case of global ROS release, the stretching re-
sults in the same ROS production pattern in both the sub-
space and the myoplasm (Fig. 6, A and B). Hence, there is
no significant net efflux of ROS to or from the subspace,
which is why the [ROS]ds and [ROS]i are consistent over
time. This reduces the rate of decline in the [ROS]ds and re-
sults in higher spark frequency during the 1–2 s compared to
the 0–1 s after stretching. Hence, simulations with local
ROS production better captured this aspect of the experi-
mental results than did the simulations with global ROS pro-
duction. Therefore, the model favors the hypothesis thatTABLE 2 Control coefficients
Bin/Bin Spark-Count Ratio
Control Coefficients for 10% Increase in the
Parameters
b k1þ k1 k2þ k2
11/10 2.085 0.059 0.005 0.105 0.575
11/20 0.203 0.025 0.001 0.027 0.077
20/21 0.043 0.022 0.003 0.007 0.252
Biophysical Journal 109(10) 2037–2050ROS signaling during stretching likely occurs locally in or
near the dyad.
The model assumes that ROS oxidation of the RyR2s is a
reversible process. To test this assumption, simulations were
performed that assumed that the oxidation of RyR2s by ROS
was irreversible, i.e., that the switch from mode 1 to mode 2
in the model was irreversible. With X-ROS signaling irre-
versibly oxidizing the RyR2s, the spark frequency increases
abruptly (Fig. 7 A) as the number of channels in mode 2 goes
from 1.1% to 85% within 1 s of stretching and to 97% within
2 s of stretching (data not shown here). The number of
channels in mode 2 continues to increase until all the chan-
nels are oxidized, but due to the depletion of SR Ca2þ
([Ca2þ]NSR), the spark frequency gradually goes to a
steady-state value and does not change even when the myo-
cyte is released from stretch (Fig. 7 B). Had the oxidation
always been irreversible, even at the nanomolar concentra-
tion of ROS (resting condition), then the average spark fre-
quency would have been much higher with all the RyR2s in
mode 2 (Fig. 7 C). The stretch-induced X-ROS signaling
would have no effect on the spark frequency. These resultsFIGURE 7 Simulations demonstrating the consequences of irreversible
oxidation of RyR2s. (A) Ca2þ spark frequency when stretch-induced ROS
results in irreversible oxidization of RyR2s. (B) The sudden increase in
Ca2þ spark frequency after stretching depletes the [Ca2þ]NSR, which stabi-
lizes at a new steady-state value. (C) The Ca2þ spark frequency when ROS
is at resting level results in irreversible oxidization of RyR2s so that almost
all RyR2s switch to mode 2 with time so that stretching has no effect on
spark rate. n ¼ 20 simulations. To see this figure in color, go online.
Modeling X-ROS Signaling 2043suggest that X-ROS signaling does not cause irreversible
oxidation, because irreversible oxidation should result in
no change in spark frequency when the myocyte is released
from stretch after 10 s of continuous stretching.
As an additional test of the model, simulation data were
compared to experiments other than those used to constrain
model parameters. The first set of experiments test how the
model responds to prolonged stretch. The experimental
Ca2þ spark counts in Fig. 5 B of Prosser et al. were normal-
ized to the minimum and maximum Ca2þ spark count of the
simulation results so that the comparisons would be more
illustrative (12). As seen in Fig. 8 A, the simulation results
in the return of spark rate to its prestretch value, as does
the experimental spark rate, and the average spark rate re-
mains the same poststretching.
The second set of simulations explores how ROS levels
increase with cyclic stretch. The normalized experimental
DCF values in Fig. 2 C of Prosser et al. (12) compare well
with experimental values over 90 s simulation time at
1 Hz and 4 Hz (Fig. 8 B). This demonstrates that X-ROS
signaling is enhanced and graded by the frequency of
stretch, as the DCF concentration is elevated at 4 Hz in com-
parison to 1 Hz. Furthermore, it suggests that the ROS dy-
namics are in agreement with experimental results. TheseFIGURE 8 Comparison of simulation results modeled for 8% stretch
(11) to experimental results for 10% stretch (12). Experimental data were
normalized to the model data to compensate for the difference in the
amount of stretch. (A) Ca2þ spark histograms for 1 s bins when the model
is simulated for 80 s and the myocyte is stretched from 10 to 70 s (n ¼ 11
simulations). The spark frequency returns to its prestretch value during the
last 10 s of stretching, as seen in the experimental data, represented by black
dots. (B) Comparison of simulated values (solid lines) to experimental
values (dashed lines) of the total concentration of activated DCF at 1 Hz
(black) and 4 Hz (blue) of cyclic stretching from 10 to 90 s. To see this
figure in color, go online.two results indicate that the model can simulate experiments
not used to constrain the model.Physiological implication of X-ROS signaling
In the beating heart, ventricular cardiac myocytes undergo
regular (rhythmic) contractions and relaxations. Accompa-
nying each contraction cycle is a period of stretching
(diastolic filling) and shortening (pumping) separated by
isometric force increase and isometric relaxation. Given
that stretching affects Ca2þ spark dynamics in ventricular
myocytes, the next three series of numerical experiments
seek to understand what impact the contraction cycle may
have on X-ROS signaling. To understand how the stretching
of ventricular myocytes can have an impact on ROS dy-
namics and subsequent Ca2þ dynamics, alternating equal
periods of stretching and release of stretch were applied at
1 Hz, 2 Hz, and 4 Hz starting from the resting unstretched
condition (Fig. 5). During this process, [ROS]ds and
[ROS]i were calculated as a function of time. No periods
of isometric force or relaxation were applied.
Oscillation of [ROS]ds and [ROS]i were observed. At
1 Hz frequency, the subspace ROS oscillates between 1.43
mM and 6.84 mM and the myoplasmic ROS oscillates be-
tween 515 nM and 734 nM (Fig. 9 A). At 2 Hz frequency,
the subspace ROS oscillates between 4.25 mM and 7.08
mM and the myoplasmic ROS between 770 nM and
831 nM (Fig. 9 B). At 4 Hz frequency, the subspace ROS os-
cillates between 5.92 mM and 7.2 mM and the myoplasmic
ROS oscillates between 889 nM and 903 nM (Fig. 9 C).
Although the sustained elevation of [ROS]i during cyclic
stretching and release of stretch has been demonstrated
experimentally (12), neither calibration of the concentration
nor oscillations of the signal could be measured.
The higher ROS concentration in the subspace is thought
to oxidize protein targets. In this model, we focused on
changes in RyR2 [Ca2þ]i sensitivity only as described in
the presentation of the model. This increased sensitivity of
RyR2 led to the increase in Ca2þ spark frequency (Fig. 10
A) and the resting [Ca2þ]i (Fig. 10 B). The Ca
2þ spark fre-
quency and [Ca2þ]i increase further as the frequency in-
creases from 1 to 2 Hz, with little additional change as
frequency increases even more to 4 Hz. This is due to the
increase in the fraction of channels (FoC) in mode 2 (M2)
with the increase in stretching-release of stretch frequency
(Fig. 10 D).
We also used the model to study the details of a more
physiological sequence of numerical experiments. In this
case, the myocyte is stretched before an electrical depolari-
zation produces an action potential (AP) that initiates EC
coupling and the [Ca2þ]i transient. The heart rate was set
to 1 Hz. Before each AP, the ventricular cardiac myocyte
was stretched for 200 ms to mimic diastolic filling starting
at one of the following times: 1) 0 ms (i.e., from 0 to
200 ms), 2) 200 ms (i.e., from 200 to 0 ms), 3) 400 msBiophysical Journal 109(10) 2037–2050
FIGURE 9 Subspace and myoplasmic ROS concentration are elevated
when the ventricular cardiac myocyte is cyclically stretched with equal pe-
riods of stretching and release of stretch from 10 to 30 s at (A) 1 Hz, (B)
2 Hz, and (C) 4 Hz. To see this figure in color, go online.
FIGURE 10 Analysis of Ca2þ dynamics for the protocol from Fig. 9
reveal that the small variations in spark rate lead to fluctuations in myoplas-
mic calcium that are governed by the fraction of channels in mode 2. (A)
Ca2þ-spark count. (B) [Ca2þ]i. (C) [Ca
2þ]NSR. (D) Fraction of channels
(FoC) in mode 2 (M2) when stretched (from 10 to 30 s) at 1 Hz, 2 Hz,
and 4 Hz (n ¼ 20 simulations). The myocyte is stretched and released
from stretch continuously from 10 to 30 s. The beats before 10 s show
the response without stretching. If the ROS-induced activation of RyRs
were not present, this level of sparks would persist regardless of stretching.
To see this figure in color, go online.
2044 Limbu et al.(i.e., from 400 to 200 ms), 4) 600 ms (i.e., from 600 to
400 ms), and 5) 800 ms (i.e., from 800 to 600 ms),
where 0 is the time of application of the stimulus for the
AP. The results of these five different simulation cases,
along with the result for control myocytes (that have not
been stretched), were compared. We observed that the
peak value of [Ca2þ]i (Fig. 11 A) and the peak value of
RyR2 Po (not shown) were maximal when the myocyte
was stretched 200 ms before the application of stimulus.
In this situation, the stimulus occurs when the ROS concen-
tration is highest. As a result, the [Ca2þ]NSR is depleted most
as well (Fig. 7 B). There is also a decline of the peak [Ca2þ]i
and [Ca2þ]NSR with each successive beat (Fig. 11).
The peak [Ca2þ]i decreases with the heartbeat number in
each of the five simulations (see, for example, Fig. 11 A). To
ascertain whether depletion of [Ca2þ]NSR is the underlying
cause for this decrease of peak [Ca2þ]i as the heartbeat
continues, similar simulations with constant [Ca2þ]NSR
were performed (Fig. 11 C) for stretching of the myocyte
200 ms before the application of stimulus. The result clearly
shows that with constant [Ca2þ]NSR, the resulting peak
[Ca2þ]i does not decrease with the heartbeat number.
To gain further insight into X-ROS signaling, the stimula-
tion protocol used in Fig. 11 was repeated and a 10 s period
of stretching was imposed from stimulation 11 through
stimulation 20. The stretching occurred 200 ms before the
11th stimulation. The peak RyR2 Po increased abruptly
with the 11th stimulation and then declined gradually
(Fig. 12 A). The peak [Ca2þ]i transient followed the same
time course (Fig. 12 B). This demonstrates that with an
abrupt increase of ROS production, EC coupling is affected
as the RyR2 Po increases and the [Ca
2þ]i also transiently in-Biophysical Journal 109(10) 2037–2050creases. The peak Po of the Ca
2þ channels increases due to
the increase in the fraction of channels in mode 2, and this
leads to an increase in the fraction of channels in the open
state of mode 2 (O2) (Fig. 12 D).Oxidative stress
OS is the condition where the concentration of ROS over-
whelms the chemical reducing power of the myocyte. This
can occur either through increased ROS production or
through a decreased reducing capacity of the myocyte. To
study the effect of sustained OS in the myocyte, simulations
were carried out with a decreased concentration of the pri-
mary cellular reducing biochemical, glutathione. Reduced
glutathione (GSH) is estimated experimentally to be pre-
sent in the rat ventricular myocytes at a concentration of
1–10 mM (20,21). Given this variability, we chose to report
the fraction of GSH. In the simulation, the GSHwas reduced
to 50% and 10% of the control level, as can occur in disease
states (22,23) (see Eqs. 6 and 7). Fig. 13 A shows that with
decreases in GSH, there is an increase in the Ca2þ spark rate
FIGURE 11 Simulations of a 200 ms period of stretching at different
points during the cardiac cycle at 1 Hz pacing during beats 11–30. Electrical
stimulation occurs at 0 ms. (A and B) Comparison of maximum values
reached by (A) [Ca2þ]i and (B) [Ca
2þ]NSR at each beat while the ventricular
cardiac myocyte is stretched from 0 to 200 ms, 200 to 0 ms, 400 to
200) ms, 600 to 400 ms, and 800 to 600 ms from the time point
of application of stimulus. The stretching protocol is shown in Fig. S1. A
maximal increase in peak Ca2þ transient amplitude is observed when the
stretching immediately precedes electrical excitation (200 to 0 ms). (C)
Decline of the peak Ca2þ seen in (A) with the continuing heartbeat during
stretching requires reduction of the SR Ca2þ content. The protocol for
200 to 0 ms (cyan bars) was used with [Ca2þ]NSR held constant. When
[Ca2þ]NSR is constant, the corresponding peak [Ca
2þ]i is also constant.
To see this figure in color, go online.
Modeling X-ROS Signaling 2045during both stretching and release of stretch. Furthermore,
the recovery of Ca2þ spark rate after stretching is slowed
when GSH decreases. This results in increased [Ca2þ]i
both at rest and during stretching (Fig. 13 B) and decreased
[Ca2þ]NSR (Fig. 13 C) as a result of the increased SR Ca
2þ
leak.
Furthermore, when the myocyte is acutely stretched
200 ms before each beat, the decrease in GSH results in a
slight increase in RyR2 Po (Fig. 14 A) and peak [Ca2þ]i
(Fig. 14 B) due to an increase in the fraction of channels
in mode 2 (Fig. 14 C). However, the peak Po and peak
[Ca2þ]i decrease with heartbeat number (Fig. 14, A and B)
due to the accompanying decrease in [Ca2þ]NSR (Fig. 14
D). This is attributable to increased [ROS]ds and [ROS]i
(Fig. 14, E and F). Thus, the model illustrates how a large
decrease in the reducing capacity of the cell could dramati-cally elevate global ROS concentrations during X-ROS
signaling, possibly to damaging levels, leading to the pro-
gression of pathological conditions.DISCUSSION
The computational model presented here suggests the un-
derlying mechanisms of regulation of EC coupling by
ROS and predicts both physiological and pathophysiolog-
ical roles of X-ROS signaling. Experiments indicate that
stretching a cardiac myocyte triggers ROS production
from Nox2, which is localized to the sarcolemmal and T-tu-
bule membranes. The model suggests the following four
predictions: 1) X-ROS signaling is local: [ROS] is produced
locally near the RyR2 complex during X-ROS signaling and
increases by an order of magnitude more than the global
ROS signal during myocyte stretching; 2) X-ROS enhances
EC coupling: X-ROS activation just before the AP, which
could correspond to ventricular filling, optimally increases
the magnitude of the Ca2þ transient; 3) X-ROS signaling
is attenuated during prolonged stretch: during prolonged
stretching, the X-ROS-induced increase in spark rate is
attenuated so that sustained stretching alone no longer
significantly increases SR Ca2þ leak; and 4) OS affects X-
ROS signaling during disease: when the chemical reducing
capacity of the cell is decreased, X-ROS signaling increases
SR Ca2þ leak and global OS, thereby increasing the possi-
bility of arrhythmia.Local ROS signaling
The model suggests that this raises local ROS in the dyadic
subspace significantly and hence affects the nearby RyR2s
by increasing the opening rate of these channels. ROS
currently cannot be imaged with the precision needed to
identify local domains. We have performed simulations in
which X-ROS signaling occurs either locally in the dyad
or globally. The simulations with local X-ROS signaling
simulate experimental data effectively. However, simula-
tions with global ROS production failed to simulate ex-
perimental data adequately. This suggests that X-ROS
signaling occurs locally. The implications of highly local-
ized signaling of X-ROS are that it enables the ROS-depen-
dent modulation of RyR2s while maintaining myoplasmic
[ROS] at relatively low levels. This has the advantage of
limiting the targets activated by X-ROS signaling.
The RyR2 channel is assumed in the model to be the main
target for X-ROS signaling. The effect of ROS on RyR2
was described by a mode-switching mechanism where the
ROS-dependent oxidation of RyR2 increases their open
probability. The model suggests that this is a reversible
process as simulations with irreversible oxidation of RyR2s
fail to simulate the experimental data. A mechanistic model
of the RyR2 and CRUs has thus been developed that is
able to demonstrate the abrupt increase in Ca2þ sparks inBiophysical Journal 109(10) 2037–2050
FIGURE 12 Continuous stretching of cells from
10 to 20 s displays a transient increase in peak
[Ca2þ]i followed by a recovery toward control.
This is caused by an increase in Po followed by a
decline in both Po and SR Ca
2þ load. The opposite
is seen during release of stretch. (A–C) Peak Po (A),
peak [Ca2þ]i (B), and peak [Ca
2þ]NSR (C) at each
beat while the ventricular cardiac myocyte is
stretched (beats 11–20) (red bars) and not stretched
(black bars). (D) Detailed breakdown of peak Po in
(A) into the fractions of channels in O1 and in O2.
To see this figure in color, go online.
2046 Limbu et al.the presence of stretch-induced ROS and the immediate fall
in the Ca2þ spark rate when ROS concentration decreases
to its control level after release of stretch. In our four-state
model of RyR2, the RyR2 behaves differently in quiescent
cells, where [ROS]ds is thought to be in the nanomolar range,
compared to acutely stretched cells, where [ROS]ds is in the
micromolar range. Upon stretching of a cardiomyocyte,
those RyR2s that are in mode 1 in the presence of a nanomo-FIGURE 13 Decreasing the reducing capacity by lowering GSH leads to
increased spark activity and Ca2þmobilization during stretching from 10 to
20 s. Shown are traces for the [GSH]/[GSH]control ratio assuming values of 1
(black) (control), 0.5 (red), and 0.1 (blue). Comparison of (A) Ca2þ-spark
count, (B) [Ca2þ]i, and (C) [Ca
2þ]NSR. To see this figure in color, go online.
Biophysical Journal 109(10) 2037–2050lar concentration of ROS can switch to mode 2, which has
higher open probability, due to the abrupt elevation of ROS
to the micromolar level, leading to the increased Ca2þ spark
rate. This increase in theCa2þ spark rate causes a correspond-
ing decrease in [Ca2þ]NSR and increase in [Ca
2þ]i. It should
be noted that there are additional targets of ROS in the
myocyte. For example, the L-type calcium channel can
display increased open probability when its thiol groups
are oxidized, and calcium/calmodulin-dependent kinase II
(CaMKII) can also be activated by oxidation (4,24,25). The
SR Ca2þ -ATPase (SERCA) can be inhibited when oxidized,
but the effect of oxidation by ROS on the Naþ-Ca2þ
exchanger (NCX) is controversial (4,26). Study of the contri-
bution of these other targets is left for future work.
The increase in intracellular [ROS] is consistent with
levels observed experimentally. The levels of ROS in
different cells can vary widely. At the low end of the spec-
trum, a study using Amplex red dye in neurons measured
[H2O2] below the detection threshold of 7 nM at rest that
increased to 66 nM after treatment with insulin (27). On
the other hand, Escherichia coli display a somewhat higher
[H2O2] of 200 nM (28). Muscle, however, seems to have
higher ROS levels. We found two studies estimating ROS
concentration in the heart. In a computational study, the Co-
tassa model has [ROS] transients peaking above 100 mM
during metabolic oscillations (29). Experimental studies in
isolated cardiac myocytes have biochemically measured
[H2O2] at 15 mM in control hearts, at 50 mM after 30 min
of ischemia, and at 100 mM 2 min after reperfusion (30).
Skeletal muscles, whose mitochondria produce ROS at
40% the rate of cardiac mitochondria, experience a 50- to
100-fold increase in ROS going from rest to exercise (18).
Cardiac myocytes seem to have the ability to survive high
ROS levels. In experiments, cardiac myocytes have been
exposed to ROS levels as high as 10 mM without cell death
(31). In fact, exposing skeletal muscle to increasing doses of
H2O2 (up to 1 mM) increases endurance (32).
FIGURE 14 Lowering of the reducing capacity
(GSH ratio) from Fig. 13 during 1 Hz pacing with
myocyte stretching for 200 ms before each stimulus
leads to increased [ROS] and increased Ca2þ
release. (A–D) Comparison of (A) peak Po, (B)
peak [Ca2þ]i, (C) the corresponding fraction of
channels (FoC) in mode 2 (open, closed, and inac-
tivated), and (D) peak [Ca2þ]NSR at each beat. (E
and F) Presence of (E) [ROS]ds and (F) [ROS]i in
the myocyte due to cyclic stretching and release
of stretch. To see this figure in color, go online.
Modeling X-ROS Signaling 2047X-ROS signaling enhances EC coupling
During contraction of the heart, cardiac cells undergo cyclic
periods of stretching and release of stretch. Comparing this
cyclic process of elongation and shortening at 1 Hz, 2 Hz,
and 4 Hz demonstrates that [ROS]ds and [ROS]i increase
with increasing frequency of stretching and release of
stretch. Accompanying the higher rate of [ROS]ds produc-
tion is a higher Ca2þ spark count, and hence a higher
[Ca2þ]i, with the cycle of stretching and release of stretch
at 2 Hz and 4 Hz compared to that at 1 Hz. This increase
seems to plateau at 4 Hz. This suggests that X-ROS
signaling may increase the gain of EC with increases in pac-
ing rate.
Furthermore, during electrical pacing, the model predicts
that X-ROS signaling leads to amodest increase in the ampli-
tude of the [Ca2þ]i transient. This was accomplished by
inducing a 200ms period of stretching (and ROS production)
at different times during the cardiac cycle. Interestingly, the
biggest effect of the frequency of stretching seems to be the
increase in myoplasmic ROS (Fig. S2 in the Supporting Ma-
terial), with a small effect on [Ca2þ]i (this matches our un-published experimental observations). This potentiation of
the [Ca2þ]i transient is maximal when the 200 ms period of
stretching immediately precedes the AP. The model shows
that under these conditions, [ROS]ds is maximal when the
AP begins and triggers the Ca2þ transient. Teleologically,
this makes sense, as the filling of the ventricles with blood
stretches the myocytes immediately before contraction.
Hence, the stretching of the ventricular wall combined with
X-ROS signaling seems to optimize Ca2þ release during
contraction. Of note, the experimentally measured increase
in free [Ca2þ]i may fall short of that predicted by the model
due to the subsequent increase in myofilament Ca2þ buff-
ering that occurs during stretching (33).X-ROS signaling is attenuated during prolonged
stretch
The model suggests that prolonged distension of the wall
(10 s), and the accompanying stretching of the myocyte, en-
hances Ca2þ release modestly. However, with prolonged
stretch, the X-ROS production is attenuated, consistentBiophysical Journal 109(10) 2037–2050
2048 Limbu et al.with experiments. Furthermore, this small potentiation of
Ca2þ release is attenuated by depletion of the NSR due to
the increased RyR2 Ca2þ leak. This is similar to the results
of Trafford and colleagues (34), which showed that
increasing RyR2 open probability pharmacologically re-
sulted in a transient increase in the Ca2þ transient, which
then returned to the control amplitude after several beats
(34). This recovery was due to changes in [Ca2þ]NSR
(34,35). The opposite effect was seen with washout, i.e.,
there was a transient decrease in Ca2þ-transient amplitude
that returned to the control level after several beats.OS affects X-ROS signaling during disease
OS occurs when the cellular ROS levels rises. The model
suggests that when the removal of ROS is impaired, the sys-
tolic and diastolic spark rates increase due to an increase in
the level of cellular ROS. An example of a disease in which
ROS removal is impaired due to reduction in the available
glutathione pool is HF (36). Increased Ca2þ leak has been
observed in HF and has been implicated in arrhythmia
(37). Although increased X-ROS signaling might not be
the primary cause of the increased leak, it could contribute
to it. Similarly, if the rate of ROS production increases, the
cellular ROS levels will also rise. X-ROS signaling is
enhanced in muscular dystrophy (mdx) by increased micro-
tubule density transmitting stretching to the NADPH oxi-
dase (13). In fact, muscle cells from mdx mice show an
increased susceptibility to OS (38,39). This increase in
SR Ca2þ leak likely plays a role in arrhythmia. In fact,
inhibition of NADPH oxidase reduces the propensity for
arrhythmia in the mdx heart (40). The model also predicts
that a significant depletion of reducing compounds could
result in a dramatic change in redox status of the myocyte,
driving the cell toward pathology. Lowering the GSH con-
centration by factors observed in disease states elevated
the [ROS]i, which significantly increased the [Ca
2þ]i and
depleted the [Ca2þ]NSR.Other considerations
During sarcomere lengthening, there is an observed increase
in force that is thought to be due to an increase in troponin
affinity for Ca2þ independent of Ca2þ level. During a single
stretch from rest, the spontaneous spark rate can double due
to X-ROS signaling. Furthermore, the model suggests that
during the initial twitch, the calcium transient amplitude in-
creases by 20%. This increase in the Ca2þ transient ampli-
tude may be partially obscured and offset by the increased
myofilament Ca2þ sensitivity, i.e., increased Ca2þ buffering,
a feature not included in the model presented here, but left
for future work. Therefore, it is possible that the stretch acti-
vation of Ca2þ release might be also involved in force-
length effects. However, that is speculative, and further
studies are planned to explore this topic more thoroughly.Biophysical Journal 109(10) 2037–2050The model suggests that during the AP, the myocyte spark
count increases by 15.6% when X-ROS signaling is added.
This means that additional sites are seeing elevated calcium
in the form of Ca2þ sparks. Others might be seeing calcium
elevations as nonspark openings (15). Low-affinity cellular
Ca2þ sensors (e.g., calmodulin, Kd 5 mM (41)), will only
be activated during RyR2 opening. Hence, the increased
spark activity, though only modestly affecting Ca2þ release,
can activate molecules such as calmodulin, which can then
act on downstream targets like CaMKII to alter cell func-
tion. In fact, there is evidence that CaMKII is activated dur-
ing stress by Nox2-ROS production at the release sites and
that CaMKII directly increases RyR2 open probability
(42,43). Dries and co-workers (42) observed that RyR2s
that are in release sites with intact dyadic structure are regu-
lated by Nox2-ROS and CaMKII during high-frequency
stimulation. However, orphaned sites without adjacent T-tu-
bules (and therefore presumably far from Nox2) did not
show the same frequency-dependent regulation by ROS
and CaMKII. Furthermore, Jian and co-workers (43) sug-
gest that the increase of RyR2 open probability with me-
chanical stress can occur via the synergistic effects of
Nox2-ROS production and CaMKII activation, as well as ni-
tric oxide synthase signaling (38). Finally, computational
modeling by Saucerman and Bers has demonstrated that
local Ca2þ signaling in the dyadic cleft affects targets of
calmodulin such as calcineurin and CaMKII differently
than in the bulk myoplasm, supporting the idea that the in-
crease in spark activity during stretching may play a further
signaling role (44).
The simulations presented here explore only the effects of
X-ROS signaling on RyR2s. However, it is likely that X-
ROS acts on multiple targets, such as CaMKII, mechano-
sensitive channels (13), and nitric oxide synthase (45), and
when these targets are affected in concert, the consequences
may be more dramatic. Inclusion of these effects likely will
be possible in the future, as we and others carry out new
relevant experiments. The experiments used to constrain
the modeling might have some of these effects present. If
this is the case, the model will need to be reparametrized
when new information is included. Hence, the effects of
X-ROS signaling are likely greater than its effects on the
size of the Ca2þ transient and will require further detailed
study.
ROS has many targets in the cell and multiple sources.
Here, we have considered ROS production by NADPH-ox-
idase in response to stretch and how that might affect the
RyR. Future work should explore other targets, such as
SERCA pumps, L-type channels, the NCX, and the sarco-
lemmal Ca2þ ATPase (4). Other sources of ROS production,
such as mitochondria and xanthine oxidase, should also be
considered.
In summary, this model for X-ROS signaling has been
validated using available data and simulates the stretch-
induced increase in spark rate and ROS production. The
Modeling X-ROS Signaling 2049model suggests that the signaling is local and affects
RyR2s in the dyad. It also suggests that as a result, the in-
crease in sparks leads to activation of local calcium-depen-
dent signaling. The model has been used to understand the
physiological implication of X-ROS signaling, suggesting
that it augments EC coupling gain with increased pacing
frequency. The model suggests that diastolic stretching of
the ventricular wall due to blood filling the ventricle opti-
mally increases Ca2þ release from the SR during systole
to maximize contraction. Furthermore, during prolonged
stretching, the stretching alone is not likely to augment cal-
cium release. During OS, however, there will be an
increased level of ROS and increased RyR2 activity due
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